Latest news with #LouisBotha
IOL News
24-05-2025
- Health
- IOL News
Point of view: understanding South Africa's healthcare system
Explore the latest findings from HQA's annual review on South Africa's healthcare system, highlighting progress in diabetes care, vaccination rates, and cancer screening, while addressing the challenges that remain Image: File South Africa's healthcare system stands at a crossroads, where ensuring quality of care is not just a goal—it's a necessity for long-term sustainability. The way patients are treated, screened, and monitored impacts everything from health outcomes to service efficiency. If we want a system that truly serves its people, we need to pay attention to the data. Fortunately, HQA, a non-profit organisation, provides an annual review of how well medical schemes are performing in clinical quality of care. This latest report, which assesses over 84% of insured beneficiaries, paints a picture of how primary care, maternity services, chronic disease management, and hospital-based care stack up. What makes HQA's review particularly valuable is its independent nature—now in its 21st year, it offers unbiased insights into where healthcare is improving and where it's falling short. 'These indicators give us a snapshot of how well we are doing—not just in treating illness, but in preventing it,' says Louis Botha, CEO of HQA. 'They also highlight where healthcare providers, funders, and patients alike can take more proactive steps.' This year, four key areas have been highlighted: diabetes care, flu vaccination for older adults, colorectal cancer screening, and breast cancer screening. Let's unpack what the numbers reveal. According to the report, diabetes is one of South Africa's fastest-growing health challenges, fuelled by poor diets and increasingly sedentary lifestyles. A 2025 health report estimated that nearly two-thirds of South African women are overweight or obese, putting them at high risk of developing diabetes. One of the most important tests for diabetes management is HbA1c testing, which tracks blood sugar levels over three months. Good control of blood sugar can prevent serious complications like vision loss, kidney failure, and amputations. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Encouragingly, 72% of beneficiaries living with diabetes had at least one HbA1c test in 2023—a huge jump from 46% in 2010. Among those enrolled in a diabetes management programme, 34% received two or more tests, in line with clinical guidelines. But the numbers vary across schemes—some report only 20% of diabetes patients getting two tests, while others reach as high as 53%. These gaps matter because access to routine testing is key to preventing complications. Every year, influenza poses a serious risk to older adults, especially those aged 65 and above. Complications like pneumonia, heart attacks, and strokes can often follow flu infections, and research shows the risk of heart attack increases up to fivefold during the first two weeks of flu. Despite this, vaccination rates remain low. In 2023, only 19% of older adults in medical schemes received their flu jab. While this is better than the 8% recorded in 2010, it's still far below ideal levels. Some schemes see uptake as low as 3%, while the best performers reach 26%. One issue is that many flu jabs are given outside traditional claims processes, during wellness days and company-sponsored vaccinations, so actual coverage may be higher than the numbers suggest. Still, with flu season approaching, getting vaccinated is an easy, effective step to protect vulnerable populations. It's not just about your own health—it helps shield family members, colleagues, and the elderly in our communities. Colorectal cancer is one of the most treatable cancers, but only if caught early. That's why regular screening is critical, particularly for people aged 50 and older. HQA's latest data tracks two forms of screening: Annual Faecal Occult Blood Test (FOBT) Colonoscopy or sigmoidoscopy every five years Although colonoscopy rates have improved, rising from 7% in 2014 to 12% in 2023, FOBT screening remains stagnant. Only 1% of beneficiaries underwent the test last year, with the highest-performing schemes reaching just 3%. This is concerning, considering the risk factors for colorectal cancer, which include being over 50, family history, poor diet, smoking, excessive alcohol consumption, and physical inactivity. Improved awareness and access to easier screening tools, such as FIT (Faecal Immunochemical Test), which can be done at home, could significantly improve detection rates. Breast cancer is one of the most common cancers among South African women, yet early detection remains the best chance of survival. HQA tracks mammography screening in women aged 50 to 74, measuring those who have had a mammogram in the past two years versus those who haven't had one in five years. The latest numbers show 24% of women in this group had a mammogram in 2023, compared to 22% in 2010. Encouragingly, the number of women who hadn't had a mammogram in five years dropped from 88% in 2016 to 65% in 2023. However, there's still a gap between the highest-performing schemes (42%) and the lowest (7%). Since most medical schemes include benefits for breast cancer screening, greater education and outreach efforts could drive better participation. The data from HQA's annual review makes one thing clear: South Africa has made progress in healthcare quality, but there's still a long road ahead. Whether it's diabetes, flu prevention, cancer screening, or access to basic care, healthcare providers, policymakers, and medical schemes must continue to focus on proactive care, not just reactive treatment. For the everyday South African, the takeaway is simple: know what benefits you have, ask the right questions, and take advantage of preventive care. The more informed we are, the better our healthcare system will serve everyone.
IOL News
10-05-2025
- Entertainment
- IOL News
A Moment in Music History: Kesivan and The Lights Record Live at the Baxter
Kesivan Naidoo, a Standard Bank Young Artist of the Year, and internationally acclaimed drummer, composer, and bandleader now based in Basel, is joined by a remarkable ensemble. Picture: Louis Botha for PACT The 'Freedom in Sound' national tour reaches its historic crescendo in the Mother City on Saturday, May 10, 2025, when Kesivan and The Lights take the stage at the iconic Baxter Concert Hall for one extraordinary night. A performance that will be captured live for the band's upcoming album and documentary, and you're invited to be part of the audience. Celebrating 30 years of South African democracy through jazz, this special concert marks the culmination of a powerful musical journey that began at Journey to Jazz in Prince Albert, swept through Durban and Johannesburg, and now comes home to Cape Town - where many of these jazz brothers first found their voices. But this isn't just another gig. This is an audience experience, where the energy in the room becomes part of the story. It's a rare opportunity to witness the making of a landmark album that honours South Africa's jazz giants - from Bheki Mseleku to Abdullah Ibrahim - while weaving in brand-new compositions and re-imaginings that speak to the present and future of this vibrant genre.
